Changes in Hong Kong stocks | Jietai Technology-P (07666) rose more than 11% in early trading MTS-128 only took half a year from PCC to completion of BD

The Zhitong Finance App learned that Jitai Technology-P (07666) rose by more than 11% in early trading. As of press release, it had risen 9% to HK$11.63, with a turnover of HK$52.703 million.

According to the news, Jietai Technology recently announced that it has reached an exclusive MTS-128 global licensing cooperation with Boulevard, a subsidiary of Deerfield. Jietai Technology will receive a down payment of 20 million US dollars, a milestone payment of up to 1.6 billion US dollars, and a potential sales share. It is currently the largest authorized transaction for domestic pre-clinical TCE projects.

CITIC Construction Investment pointed out that the MTS-128 only took half a year from PCC to completion of the BD, verifying the efficient implementation ability of the company's “platform cooperation+product cooperation” two-wheel drive business model. MTS-128 is a three-specific TCE developed and optimized by AIprotein driven by the nanoForge platform. As aILnP, airNA, and AITEM platforms continue to produce high-quality assets, the value and commercial implementation capabilities of the company's nanoForge platform are expected to be released at an accelerated pace.